Related Experiment Video

Updated: Jul 19, 2025

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

15.8K

The continuing need for therapeutic agents for respiratory syncytial virus infection

Norbert J Roberts1,2

  • 1Division of Infectious Diseases and Immunology, Department of Medicine, New York University Grossman School of Medicine, New York, NY, USA.

Antiviral Chemistry & Chemotherapy
|August 14, 2023
PubMed

Insights

Respiratory syncytial virus (RSV) infections are common and recurring. While vaccines are in development, new therapies are crucial for those not protected or unable to be vaccinated, especially high-risk groups.

Area of Science:

  • Virology and Immunology
  • Infectious Diseases
  • Vaccinology and Therapeutics

Background:

  • Respiratory syncytial virus (RSV) infections cause recurrent illness throughout life, despite initial immunity.
  • Current vaccine development shows promise, but no licensed RSV vaccine is available.
  • Certain populations may not achieve adequate protection from vaccines or cannot be vaccinated.

Purpose of the Study:

  • To highlight the ongoing need for effective therapeutic agents against respiratory syncytial virus.
  • To emphasize the importance of treatments for individuals at higher risk of severe RSV infection.
  • To present a perspective on the current landscape of RSV prevention and treatment.

Main Methods:

  • Literature review and synthesis of current knowledge on RSV.
  • Analysis of the limitations of existing and developing preventive strategies.
  • Discussion of the therapeutic landscape for RSV infections.

Main Results:

  • Despite advances in vaccine research, licensed vaccines for RSV remain unavailable.
  • Vaccination may not provide complete or adequate protection for all populations.
  • A significant portion of the population remains vulnerable to RSV reinfection.

Conclusions:

  • There is a persistent and critical need for effective therapeutic interventions for RSV.
  • Therapeutic agents are essential to manage RSV infections, particularly in vulnerable and high-risk individuals.
  • Continued research and development of treatments are vital for public health.
Keywords:
Respiratory syncytial virusantiviral agentssusceptibility to infectiontherapeutic agentsvaccines

More Related Videos

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

10.9K
An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

7.9K

Related Concept Videos

Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
163
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
489
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
290
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
338
Upper Respiratory Drugs: Decongestants01:27

Upper Respiratory Drugs: Decongestants

Decongestants are a class of medications used primarily to alleviate nasal congestion, a common symptom resulting from allergies, colds, sinusitis, and other upper respiratory tract infections. These drugs work by activating α-adrenergic receptors, constricting small blood vessels in the nasal membranes. This action results in the opening of clogged nasal passages, thereby facilitating sinus drainage and relieving congestion.
Most decongestants are readily available over-the-counter in...
264
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
676